2003

1. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: Randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)

   Lancet, Vol. 362, Núm. 9386, pp. 782-788